Treatment of Metastatic Colorectal Cancer: ASCO GuidelineVan K. Morris, Cathy Eng|Journal of Clinical Oncology|2022Cited by 580
ctDNA applications and integration in colorectal cancer: an NCI Colon and Rectal–Anal Task Forces whitepaperArvind Dasari, Scott Kopetz, Van K. Morris et al.|Nature Reviews Clinical Oncology|2020Cited by 365
Fruquintinib versus placebo in patients with refractory metastatic colorectal cancer (FRESCO-2): an international, multicentre, randomised, double-blind, phase 3 studyArvind Dasari, Cathy Eng, Tibor Csőszi et al.|The Lancet|2023Cited by 319
Classifying Colorectal Cancer by Tumor Location Rather than Sidedness Highlights a Continuum in Mutation Profiles and Consensus Molecular SubtypesJonathan M. Loree, Scott Kopetz, Allan Andresson Lima Pereira et al.|Clinical Cancer Research|2017Cited by 318
Cytokine profile and prognostic significance of high neutrophil-lymphocyte ratio in colorectal cancerZ.-Y. Chen, Scott Kopetz, Kanwal Raghav et al.|British Journal of Cancer|2015Cited by 148